Bioinformatics analysis highlighted the NF‐κB signaling pathway as a critical role for its anti‐inflammatory activity, with further validation confirming its role in DBD's therapeutic mechanism for RA. The gene discussed is NFKB1; the disease is rheumatoid arthritis.